SLC16A1 and irritable bowel syndrome: Early studies by Thibault et al., assessing butyrate absorption in diseased colon tissue from patients with IBD, familial adenomatous polyposis (FAP), and CRC, highlighted a drastic reduction in MCT1 mRNA in diseased tissues, correlating with the degree of inflammation.